Lyra Therapeutics, Inc. (LYRA)
OTCMKTS · Delayed Price · Currency is USD
0.2800
-0.0600 (-17.65%)
At close: Aug 10, 2026
Lyra Therapeutics Market Cap
Lyra Therapeutics has a market cap or net worth of $496.97 thousand as of August 11, 2026. Its market cap has decreased by -95.36% in one year.
Market Cap
496.97K
Enterprise Value
14.86M
Revenue
398.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.28
ChartMarket Cap Chart
Since May 1, 2020, Lyra Therapeutics's market cap has decreased from 230.14M to 496.97K, a decrease of -99.78%. That is a compound annual growth rate of -62.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 496.97K | -90.91% |
| Dec 31, 2025 | 5.47M | -59.54% |
| Dec 31, 2024 | 13.51M | -95.09% |
| Dec 29, 2023 | 275.43M | 175.60% |
| Dec 30, 2022 | 99.94M | 76.26% |
| Dec 31, 2021 | 56.70M | -61.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| May 1, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Avenue Therapeutics | 840.55K |
| Agentix | 801.34K |
| Nextel Medical | 790.37K |
| Emmaus Life Sciences | 772.07K |
| SQZ Biotechnologies Company | 707.79K |
| NKGen Biotech | 666.07K |
| Burzynski Research Institute | 591.52K |
| Protagenic Therapeutics | 560.26K |